secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prime Medicine, Inc. (PRME)
CIK:        0001894562
Form:       8-K
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0001628280-25-029646
Event type: other_material
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Prime Medicine shareholders elect Cahill and Nelsen as Class III directors, ratify PwC
--------------------------------------------------------------------------------

- Thomas Cahill elected with 74,446,103 For, 8,336,569 Withheld, 15,311,067 broker non-votes.
- Robert Nelsen elected with 70,607,668 For, 12,175,004 Withheld, 15,311,067 broker non-votes.
- Ratification of PricewaterhouseCoopers as auditor passed: 98,008,974 For, 42,555 Against, 42,210 Abstentions.
- Quorum of 98,093,739 shares present (74.8% of 131,160,842 outstanding shares).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894562/000162828025029646/0001628280-25-029646-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894562/000162828025029646/prme-20250604.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-029646

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer